World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
97
Citations
40497
World Ranking
9172
National Ranking
511

Overview

Norbert Schmitz is affiliated with the University of Münster in Germany and has contributed extensively to medical research, particularly in the field of lymphoma and related hematological disorders. Their work spans multiple aspects of oncology, pathology, immunology, and genetics, with a significant focus on lymphoma diagnosis and treatment.

Their research interests cover several specialized areas, including:

  • Lymphoma Diagnosis and Treatment
  • CAR-T cell therapy research
  • CNS Lymphoma Diagnosis and Treatment
  • Chronic Lymphocytic Leukemia Research
  • Viral-associated cancers and disorders
  • T-cell and Retrovirus Studies
  • Acute Lymphoblastic Leukemia research

The scientist has authored numerous papers in reputable journals. Notable recent publications include:

  • "International prognostic indices in diffuse large B-cell lymphoma: a comparison of IPI, R-IPI, and NCCN-IPI," published in 2020 in Blood
  • "Alemtuzumab plus CHOP versus CHOP in elderly patients with peripheral T-cell lymphoma: the DSHNHL2006-1B/ACT-2 trial," Leukemia, 2020
  • "A randomized phase 3 trial of auto vs. allo transplantation as part of first-line therapy in poor-risk peripheral T-NHL," Blood, 2020
  • "Outcome of allogeneic transplantation for mature T-cell lymphomas: impact of donor source and disease characteristics," Blood Advances, 2021
  • "Rituximab plus high-dose chemotherapy (MegaCHOEP) or conventional chemotherapy (CHOEP-14) in young, high-risk patients with aggressive B-cell lymphoma: 10-year follow-up of a randomised, open-label, phase 3 trial," The Lancet Haematology, 2021

Schmitz has published predominantly in the following venues:

  • Blood
  • HemaSphere
  • Hematological Oncology
  • Leukemia
  • Blood Advances

Their frequent collaborators include:

  • Marita Ziepert
  • Georg Lenz
  • Bettina Altmann
  • Bertram Glaß
  • Peter Dreger

Schmitz's work contributes notably to the subfields of pathology and forensic medicine, oncology, neurology, immunology, and genetics. With 178 publications classified under Medicine, the scientist's research reflects a broad and integrated approach toward understanding and treating hematologic malignancies.

Best Publications

  • Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: results of a prospective randomized study of the German Low-Grade Lymphoma Study Group

    Wolfgang Hiddemann;Michael Kneba;Martin Dreyling;Norbert Schmitz

  • Salvage Regimens With Autologous Transplantation for Relapsed Large B-Cell Lymphoma in the Rituximab Era

    Christian Gisselbrecht;Bertram Glass;Nicolas Mounier;Devinder Singh Gill

  • Retinoic acid and arsenic trioxide for acute promyelocytic leukemia

    F. Lo-Coco;G. Avvisati;M. Vignetti;C. Thiede

  • Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial

    Norbert Schmitz;Beate Pfistner;Michael Sextro;Markus Sieber

  • Six versus eight cycles of bi-weekly CHOP-14 with or without rituximab in elderly patients with aggressive CD20+ B-cell lymphomas: a randomised controlled trial (RICOVER-60)

    Michael Pfreundschuh;Joerg Schubert;Marita Ziepert;Rudolf Schmits

  • Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL

    Michael Pfreundschuh;Lorenz Trümper;Marita Kloess;Rudolf Schmits

  • Randomised trial of filgrastim-mobilised peripheral blood progenitor cell transplantation versus autologous bone-marrow transplantation in lymphoma patients

    N Schmitz;P Dreger;D.C Linch;A.H Goldstone

  • Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation

    Richard E. Champlin;Norbert Schmitz;Mary M. Horowitz;Bernard Chapuis

  • Standard International Prognostic Index Remains a Valid Predictor of Outcome for Patients With Aggressive CD20+ B-Cell Lymphoma in the Rituximab Era

    Marita Ziepert;Dirk Hasenclever;Evelyn Kuhnt;Bertram Glass

  • Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group.

    Norbert Schmitz;Lorenz Trümper;Marita Ziepert;Maike Nickelsen

  • Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL.

    Michael Pfreundschuh;Lorenz Trümper;Marita Kloess;Rudolf Schmits

  • MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma

    Heike Horn;Marita Ziepert;Claudia Becher;Thomas F. E. Barth

  • Chemoresistant or aggressive lymphoma predicts for a poor outcome following reduced-intensity allogeneic progenitor cell transplantation: an analysis from the Lymphoma Working Party of the European Group for Blood and Bone Marrow Transplantation

    Stephen P. Robinson;Anthony H. Goldstone;Stephen Mackinnon;Angelo Carella

  • Autologous Stem-Cell Transplantation As First-Line Therapy in Peripheral T-Cell Lymphomas: Results of a Prospective Multicenter Study

    Peter Reimer;Thomas Rüdiger;Eva Geissinger;Florian Weissinger

  • Improved Outcomes With Retinoic Acid and Arsenic Trioxide Compared With Retinoic Acid and Chemotherapy in Non-High-Risk Acute Promyelocytic Leukemia: Final Results of the Randomized Italian-German APL0406 Trial.

    Uwe Platzbecker;Giuseppe Avvisati;Laura Cicconi;Christian Thiede

  • CNS International Prognostic Index: A Risk Model for CNS Relapse in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP

    Norbert Schmitz;Samira Zeynalova;Maike Nickelsen;Roopesh Kansara

  • G-CSF-MOBILIZED PERIPHERAL BLOOD PROGENITOR CELLS FOR ALLOGENEIC TRANSPLANTATION : SAFETY, KINETICS OF MOBILIZATION, AND COMPOSITION OF THE GRAFT

    P Dreger;T Haferlach;V Eckstein;S Jacobs

  • Reduced-Intensity Conditioning Compared With Conventional Allogeneic Stem-Cell Transplantation in Relapsed or Refractory Hodgkin's Lymphoma: An Analysis From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

    Anna Sureda;Stephen Robinson;Carmen Canals;Angelo M. Carella

  • Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

    Peter Dreger;Hartmut Döhner;Matthias Ritgen;Sebastian Böttcher

  • Myeloablative radiochemotherapy followed by autologous stem cell transplantation in first remission prolongs progression-free survival in follicular lymphoma: results of a prospective, randomized trial of the German Low-Grade Lymphoma Study Group.

    Georg Lenz;Martin Dreyling;Eva Schiegnitz;Roswitha Forstpointner

Frequent Co-Authors

Michael Pfreundschuh
Michael Pfreundschuh Saarland University
Markus Loeffler
Markus Loeffler Leipzig University
Michael Kneba
Michael Kneba Kiel University
Andreas Rosenwald
Andreas Rosenwald University of Würzburg
Anna Sureda
Anna Sureda Autonomous University of Barcelona
Martin Dreyling
Martin Dreyling Ludwig-Maximilians-Universität München
Lorenz Trümper
Lorenz Trümper University of Göttingen
Anthony D. Ho
Anthony D. Ho University Hospital Heidelberg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn't have to be limited to traditional routes. There are many flexible online degrees that support diverse healthcare careers. For example, those interested in pharmaceuticals can consider pursuing a pharmacy degree online, which allows students to balance study and other commitments.

If you're drawn to health data and management, enrolling in rhit programs online is a great way to gain specialized skills in managing patient records and information systems. Careers in medical administration are also accessible via affordable online options, and it's helpful to research medical billing and coding cost to find budget-friendly training programs.

Nursing is another crucial pathway. Becoming a nurse practitioner offers advanced opportunities, and students can save money by researching the cheapest np school options available through online study.

Each of these pathways offers flexibility, affordability, and the chance to shape a fulfilling healthcare career.

Best Scientists Citing Norbert Schmitz

Trending Scientists

Recently Published Articles